Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada
Conditions
- Age-related Macular Degeneration (AMD)
- Central Retinal Vein Occlusion (CRVO)
- Diabetic Macular Edema (DME)
Interventions
- DRUG: Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
Sponsor
Bayer
Collaborators